Insights into the Lid Margin: Characterization of Membrane Associated Mucins in Ocular Surface Disease

Recruiting
18 years - 100 years
All
1 Location

Brief description of study

Dry eye disease affects millions of people worldwide and due to an incomplete understanding of the pathogenesis of the disease, it is widely underdiagnosed and undermanaged by clinicians. Understanding the contribution of the proteins involved in maintaining boundary lubrication between the ocular surface and eyelids, specifically mucins, may lead to better understanding of disease and potentially to earlier diagnosis of dry eye. The aim of this project is to investigate mucins on the ocular surface and examine differences in people with and without dry eye disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Dry Eyes
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria: 

All subjects must be:

oAble to understand and sign an informed consent and HIPAA privacy document.

o18 years of age or older.

oAble and willing to follow protocol instructions.

Subjects will be telephone screened to determine if the subject falls into either Group 1: Dry Eye or Group 2: Normal, depending on the type of subjects still needed to meet enrollment goals.

Group 1 Dry Eye Disease Inclusion:

OSDI score > 33 (administered via telephone screener)

Group 2 Normal Inclusion:

OSDI score < 10 (administered via telephone screener)

All subjects that meet the inclusion/exclusion criteria and consent to participating in the study will be enrolled. 

Data obtained will then be segregated based on clinical findings for later analysis.

 

Exclusion Criteria: 

1.     Under the age of 18

2.Current contact lens wearer (any wear of contact lenses in the past 3 months)

3.Use of any of the following ophthalmic medication within 30 days: antibiotics, anti-fungal, anti-allergy, anti-inflammatory, anti-glaucoma, lifitegrast, restasis

4.Use of artificial tears within 2 days of study visit

5.Active ocular infection or acute allergic conjunctivitis

6.Transmissible or contagious disease such as HIV, TB, measles, meningitis, etc.

7.Significant conjunctival scarring, obvious meibomian gland dysfunction, or other serious ocular condition

8.History of ocular surgery in the past 12 months

9.Participation in a clinical trial involving a drug or device in the past 30 days

 

10.Pregnant or nursing by self-report

Updated on 04 Aug 2024. Study ID: 1908362633

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team